Results 91 to 100 of about 44,802 (314)
This graphical abstract summarizes the study design and main findings in patients with newly diagnosed left ventricular systolic dysfunction and concomitant arrhythmia undergoing early rhythm control under wearable cardioverter‐defibrillator protection.
Joerg Yogarajah +10 more
wiley +1 more source
La amiodarona es uno de los antiarrítmicos de uso más extendido, pero de la misma forma es un medicamento con efectos adversos bien conocidos y a múltiples niveles; uno de los más importantes es el que se describe para el tejido tiroideo. Cerca de 80% de
Erwing A Vargas +4 more
doaj
Proarrhythmic Antiarrhythmic [PDF]
Mark, Pollet, Mohammad, Saeed
openaire +2 more sources
ABSTRACT Catheter ablation is an established therapy for ventricular tachycardia (VT); however, hemodynamic instability frequently limits procedural mapping and success. Temporary mechanical circulatory support (tMCS) devices are increasingly used to maintain end‐organ perfusion during VT ablation, yet their impact on clinical outcomes remains ...
Ahmed Nazmy +19 more
wiley +1 more source
ABSTRACT Background While various pulsed field ablation (PFA) systems for atrial fibrillation (AF) ablation have become available in recent years, data comparing long‐term efficacy outcomes remain limited. Purpose To compare long‐term efficacy outcomes of two commercially available PFA systems to perform pulmonary vein isolation (PVI) for AF in a ...
Marisa van der Graaf +18 more
wiley +1 more source
Bifunctional agents for reperfusion arrhythmias: Novel hybrid vitamin E/class I antiarrhythmics
We have synthesized a series of hybrid compounds combining the pharmacophoric redox moieties of vitamin E and key features responsible for the antiarrhythmic properties of the class I antiarrhythmics procainamide and lidocaine. Procainamide analogue (2a)
Chryselis, M. +6 more
core
Displays bar graphs showing outcome rates stratified by clinical and hemodynamic variables. Asterisks (*) denote statistically significant differences (p ≤ 0.05). “NS” indicates non‐significant comparisons. Percentages are shown above each bar. The top panel corresponds to acute kidney injury (blue bars), and the bottom panel corresponds to acute ...
Tess Calcagno +23 more
wiley +1 more source
ABSTRACT Background Effective monitoring of atrial fibrillation (AF) recurrence following catheter ablation is crucial for optimizing patient outcomes. Various monitoring strategies exist, but effectiveness comparisons remain underexplored. Objective This study compares the recurrence of atrial arrhythmias detected by continuous versus patch ECG ...
Chinmaya Mareddy +24 more
wiley +1 more source
ABSTRACT Ulcerative colitis (UC) and Crohn's disease (CD) are increasingly prevalent in the Asia Pacific region, necessitating updated, region‐specific guidance on advanced therapies. Targeted small molecule agents, such as filgotinib, tofacitinib, upadacitinib, etrasimod, and ozanimod; and the IL‐23 p19 inhibitors (guselkumab, mirikizumab ...
Choon Jin Ooi +34 more
wiley +1 more source
Therapy for patient with atrial fibrillation: in search of a balance between efficacy and safety
This paper analyzes aspects of the efficacy and safety of antiarrhythmic drugs in the treatment of atrial fibrillation. It considers drug-drug interactions of antiarrhythmics with other drugs, especially in the near circle, i.e.
Yakov G. Bozhko +2 more
doaj +1 more source

